Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Schwannomas are benign, slow-growing tumors that develop from Schwann cells in the nerve sheath and can occur in peripheral, cranial, or autonomic nerves. Foramen ovale schwannomas are a rare variant in the head and neck region representing 1%-2% of all intracranial schwannomas, with parapharyngeal space involvement complicating surgical resection. A 48-year-old male presented with headaches after an episode of light-headedness along with facial pain. MRI showed a well-defined lesion measuring 50 × 40 × 20 mm in the left masticator space, extending superiorly up to the left temporal lobe. CT imaging revealed a 28 × 25 × 31-mm lesion in the left masticator space, extending through the foramen ovale into the medial left temporal lobe. The tumor was classified as Type ME under the Yoshida and Kawase system, involving both the middle cranial fossa and extracranial extension. A minimally invasive endoscopic transnasal approach was used for tumor resection, prioritizing preservation of the internal maxillary and carotid arteries. This approach was selected for its reduced morbidity and quicker postoperative recovery, as the tumor's medial location made it amenable to endoscopic access. The patient had an uneventful recovery. No new neurological deficits were reported at follow-up, and facial pain improved significantly. This report reviews the current literature on the diagnosis and management of trigeminal schwannoma, highlighting minimally invasive techniques as effective alternatives to traditional surgical approaches.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12356661PMC
http://dx.doi.org/10.1155/crot/1152945DOI Listing

Publication Analysis

Top Keywords

foramen ovale
12
endoscopic transnasal
8
facial pain
8
left masticator
8
masticator space
8
space extending
8
left temporal
8
temporal lobe
8
minimally invasive
8
transnasal excision
4

Similar Publications

Background: Young adults account for up to 15% of all ischemic strokes, yet data from Latin America remain scarce. Understanding their clinical profile and outcomes is essential to inform targeted interventions and public health strategies. We aimed to characterize demographics, vascular risk factors, stroke etiology, access to acute reperfusion therapies, and 90-day outcomes in Argentine patients aged 18-50 years with ischemic stroke.

View Article and Find Full Text PDF

Objective: Patent foramen ovale (PFO), a prevalent congenital cardiac defect, is linked to clinical conditions such as cryptogenic stroke and migraine. The genetic underpinnings of PFO remain poorly elucidated, particularly in Tibet. This study aimed to identify potential pathogenic mutations in Tibetan PFO patients via whole exome sequencing (WES) to clarify its genetic basis.

View Article and Find Full Text PDF

Totally implantable venous access ports (TIVAPs) are commonly used for patients undergoing chemotherapy and long-term repeated infusions. The incidence of thrombosis is low and rarely leads to serious complications. We report a case of right atrial thrombosis and paradoxical embolism in a 58-year-old male with atrial fibrillation (AF) and patent foramen ovale (PFO) 28 months after TIVAP implantation.

View Article and Find Full Text PDF

Background: The Food and Drug Administration has approved percutaneous atrial septal defect (ASD) and patent foramen ovale (PFO) closure devices for hemodynamically significant interatrial shunts, paradoxical emboli including stroke, and decompression sickness. We aimed to study the trends in utilization and reimbursements of transcatheter ASD/PFO closure devices.

Aim: To analyze trends in utilization and Medicare reimbursements for transcatheter ASD/PFO closure procedures from 2013 to 2022.

View Article and Find Full Text PDF

Background: Carcinoid Heart Disease (CHD) primarily affects the right heart valves, while left heart involvement is rare and often associated with a patent foramen ovale (PFO). Early identification of a PFO in CHD can be critical to patient outcomes. A 61-year-old woman with metastatic neuroendocrine tumor presented with worsening breathlessness and hypoxemia.

View Article and Find Full Text PDF